Series B - Abbisko Therapeutics - Mar 21, 2019 Funding Round Profile - Cointime

Bitcoin $79,562.09 +3.98%
Ethereum $3,203.90 +5.01%
BNB $635.35 +1.39%
Optimism $1.66 +1.10%
Arbitrum $0.64 +4.60%
Solana $205.35 +1.08%
Polygon $0.41 +5.51%
Cosmos $5.24 +9.72%
Avalanche $31.89 +7.79%

Bitcoin $79,562.09 +3.98%
Ethereum $3,203.90 +5.01%
BNB $635.35 +1.39%
Optimism $1.66 +1.10%
Arbitrum $0.64 +4.60%
Solana $205.35 +1.08%
Polygon $0.41 +5.51%
Cosmos $5.24 +9.72%
Avalanche $31.89 +7.79%

Abbisko Therapeutics

company

Funding Round

Series B

Money Raised

$ 42M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 7, 2017	Series A	$ 28M	Lilly Asia Ventures	Detail